Conference item icon

Conference item

Azacitidine (AZA) prolongs overall survival in older patients with acute myeloid leukemia (AML) with poor prognostic karyotypes compared with conventional care regimens (CCR)

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
RDM
Subgroup:
RDM Strategic
Oxford college:
St Annes College; St Annes College
Role:
Author
ORCID:
0000-0003-3931-0914
Expand authors...
Publisher:
American Society of Hematology Publisher's website
Volume:
128
Issue:
22
Pages:
1638
Publication date:
2016-12-01
Acceptance date:
2017-12-01
ISSN:
0006-4971 and 1528-0020
Pubs id:
pubs:907204
URN:
uri:b6d443b7-e9f2-422b-8f6d-de859409e9d2
UUID:
uuid:b6d443b7-e9f2-422b-8f6d-de859409e9d2
Local pid:
pubs:907204

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP